Vivos Therapeutics, Inc. Goodwill & Intangibles Disclosure
NOTE 5 - GOODWILL AND INTANGIBLE ASSETS
Goodwill
Goodwill of $2.8 million as of December 31, 2024 and 2023, consist of the following acquisitions (in thousands):
| Acquisitions | 2024 | 2023 | ||||||
| BioModeling | $ | 2,619 | $ | 2,619 | ||||
| Empowered Dental | 52 | 52 | ||||||
| Lyon Dental | 172 | 172 | ||||||
| Total goodwill | $ | 2,843 | $ | 2,843 | ||||
Intangible Assets
As of December 31, 2024 and 2023, identifiable intangible assets were as follows (in thousands):
| 2024 | 2023 | |||||||
| Patents and developed technology | $ | 2,302 | $ | 2,302 | ||||
| Trade name | 330 | 330 | ||||||
| Other | 27 | 27 | ||||||
| Total intangible assets | 2,659 | 2,659 | ||||||
| Less accumulated amortization | (2,289 | ) | (2,239 | ) | ||||
| Net intangible assets | $ | 370 | $ | 420 | ||||
Amortization expense of identifiable intangible assets was less than $0.1 million for the years ended December 31, 2024 and 2023. The estimated future amortization of identifiable intangible assets is as follows (in thousands):
| As of December 31, | ||||
| 2025 | 50 | |||
| 2026 | 35 | |||
| 2027 | 29 | |||
| 2028 | 29 | |||
| 2029 | 29 | |||
| Thereafter | 198 | |||
| Total | $ | 370 | ||
Want the next Vivos Therapeutics, Inc. goodwill & intangibles disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Vivos Therapeutics, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2024 | Mar 31, 2025 | Showing above |
| 2022 | Mar 30, 2023 | |
About Goodwill & Intangibles Disclosures
Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.
Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.